GLP-1s and anhedonia: the death of dopamine snacking

21 May 2026

GLP-1 drugs are reshaping cravings, impulse eating and reward-driven snacking, forcing food manufacturers to rethink indulgence, functionality and the future of emotional eating.

Read full article at Beverage Daily